We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Stay up to date on the topics that matter to you

ACROBiosystems

ACROBiosystems is a cornerstone enterprise of the pharmaceutical and biotechnology industries. Our mission is to help overcome challenges with innovative tools and solutions from discovery to the clinic. We supply life science tools designed for discovery research and scalable to the clinical phase and beyond. By consistently adapting to new regulatory challenges and guidelines, we deliver solutions, whether it comes through recombinant proteins, antibodies, assay kits, GMP-grade reagents, or custom services. We empower scientists and engineers dedicated to innovation to simplify and accelerate the development of new, better, and more affordable medicine. Our way of addressing challenges in biologics development is to offer a comprehensive array of tools and solutions designed for each development phase. Starting from discovery and development and moving beyond commercialization, we strive to deliver high-quality solutions that support each step of the development process. This means bringing together innovation and technology through product development and collaborations to help our customers achieve translatable results in the clinic and beyond.

Latest ACROBiosystems Content

Protein Markers, Streptavidin Series, Antibodies, Isotype Controls, Key Reagents for MPCLIA, Cell Culture Related Reagents

ComboX: A Combination of Universal Solutions

Whether you are engaged in basic researcher or a drug developer, ComboX is the versatile solutions that supports a wide range of biological experiments. We invite you to explore this portfolio and join us in driving innovation in life science and bio

Antiboidy-drug conjugation; site-specific conjugation; Glycan -mediated conjugation

AGLink DAR2&4 Site-Specific Conjugation Kits for Early-Stage Research and Biological Experiments in the Field of Conjugated Drugs

Through our collaboration with Glyco-Therapy Biotechnology Co., Ltd., we have introduced the AGLink® DAR2&4 site-specific conjugation kit. Visit this page to explore the cutting-edge developments in antibody-drug conjugation technologies, understand

TMi10 - Peter Hseuh

Enhancing Drug Development Through Improved Screening Strategies

In this episode, we are joined by Peter Hsueh, Marketing Product Manager at ACROBiosystems, who will discuss innovative screening strategies. He will reveal how these strategies are transforming drug development and paving the way for breakthroughs in medicine.

A gloved hand holds a six-well petri dish while media is pipetted into it.

Cell Culture Contamination in Research and Development

Cell culture underpins many aspects of research and development. In this article, we hear from three experts working in or alongside academic, industry and clinical settings to help ensure the integrity and safety of cells and cell-derived products.

FcRn binding kit；FcRn；neonatal Fc receptor; Antibody drug screening；TR-FRET; FcR； Antibody screening；FcRn affinity；antibody half life

FcRn Binding Kit: Empowering High-Throughput Antibody Drug Screening

The interactions between FcRn and IgG are strongly associated with the development of antibody drugs and targeting FcRn presents an effective therapeutic strategy to reduce serum IgG levels in autoimmune diseases. Using the FcRn Binding Kit (TR-FRET): unleashing the potential of high-throughput antibody drug screening, enabling rapid progress in your research endeavors.

mycoplasma product

Unveiling Mycoplasma Threats: Precision Protection for Your Cell Culturing

Ensuring the safety and quality of your biological products is our top priority. Mycoplasma, a tiny prokaryote, poses a significant contamination risk by evading 0.2 µm filters and thriving in diverse environments.

A gloved hand pipettes into a multi well tray

App Note / Case Study

Rapidly Detect Mycoplasma Contamination

This info kit highlights a rapid detection kit for the sensitive and reliable detection of mycoplasma in biological products.

Envelope Glycoprotein E (gE); gH&gL; gI&gE; Specific antibodies; ELISA/ ELISpot kits

Vaccine Evaluation Reagents: Solutions for VZV Vaccines Development

The overall solution for VZV vaccine R&D from manufacturing to clinical research, accompany you in the whole process of VZV vaccine development! Utilizing high-quality antigens, antibodies, and ELISA/ELISpot assay kits for both humoral and cellular immune assessment.

GMP Grade GFG-8b

High-Quality GMP Grade FGF-8b: Efficient Dopaminergic Neuronal Differentiation from iPSCs

Consistent GMP-grade products are crucial as key raw materials for safe and reliable cell manufacturing. We adhere to stringent regulatory guidelines to provide high-quality GMP biomaterials for various cell culture and differentiation.

Front cover of issue 36 of <i>The Scientific Observer<i>, featuring Victoria Gray

The Scientific Observer Issue 36

In this issue, we hear from Victoria Gray, the first person to receive a CRISPR cell-based gene therapy for sickle cell disease (SCD). She shares her experiences of the life-changing therapy and talks about the struggles faced by SCD patients and the broader implications of gene therapy accessibility.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter